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Hepatitis A virus infections and outbreaks in asylum
seekers arriving to Germany, September 2015 to
March 2016
Kai Michaelis1, Jürgen J Wenzel2, Klaus Stark1 and Mirko Faber1
From September 2015 to March 2016, hepatitis A notiﬁcations in Germany increased by 45% to 699 cases compared to 482
cases in the same period of the previous year. Children aged ﬁve to nine years were predominantly affected (22% of all cases in
this period). We hypothesized that this increase could be explained by the marked inﬂux of asylum seekers in this time period.
We analysed national surveillance data and estimated the number of imported and autochthonous hepatitis A cases in asylum
seekers. We also investigated molecular signatures of hepatitis A viruses sampled from asylum seekers to identify chains of
transmission. We found that 40% (278 cases) of all 699 hepatitis A cases notiﬁed between September 2015 and March 2016
in Germany concerned asylum seekers. Most infections were acquired abroad, but at least 24% accounted for autochthonous
infections. Among asylum seekers, children aged ﬁve to nine years were overrepresented with 97 of 278 (35%) notiﬁed cases.
The analysed hepatitis A virus sequences were primarily subgenotype IB strains and clustered with previously isolated samples
from the Middle East, Turkey, Pakistan and East Africa. Except one transmission from an asymptomatic child to a nursery nurse
working in a mass accommodation, we are not aware of infection chains involving asylum seekers and German residents. We
conclude that asylum-seeking children and adolescents are susceptible to hepatitis A virus infections, particularly children aged
ﬁve to nine years. Measures to prevent secondary infections in asylum seekers such as extended hygiene measures and post-
exposure prophylaxis seem advisable.
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INTRODUCTION
In 2015, ongoing conﬂicts in Africa and Asia, particularly in the
Middle East led to a large inﬂux of asylum seekers into the EU,
culminating in the second half of the year.1 By the end of 2015,
Germany hosted more than one million new asylum seekers most of
them ﬂeeing from those conﬂict regions.2 Between September 2015
and March 2016, parallel to peaking numbers of asylum seekers
arriving in Germany, notiﬁed cases of hepatitis A in Germany
increased substantially. Thereafter case counts returned to levels of
preceding years.
Hepatitis A virus (HAV) infections occur in people of all ages. The
virus is the causative agent of hepatitis A, a viral inﬂammatory disease
that affects the liver. The severity of the disease ranges from a mild
illness lasting a few weeks to a severe illness lasting several months.3
Symptomatic disease is associated with nausea, fever, abdominal pain,
fatigue and typical signs of jaundice. In general, symptoms are more
severe in the elderly and in people with weakened immune systems.4
Patients with chronic liver diseases are at risk to develop fulminant
hepatitis A with a possible fatal outcome.5 In young children, hepatitis
A is often asymptomatic. The period of maximum infectiveness spans
one to two weeks before symptom onset until a few days after the
onset of jaundice.
HAV is typically transmitted via the faecal–oral route. The virus
particles are extraordinarily robust and generally stable at high
temperatures, very low pH values or other harsh environmental
conditions.6 Living conditions such as poor hygiene, crowded housing,
shortage of clean drinking water or consumption of contaminated
food are well-established factors, known to trigger the spread of HAV.7
As many of the asylum seekers experienced at least an episode of
serious living conditions during the journey from their country of
origin to the host country in Europe, they are potentially exposed to
HAV.8,9
In our report, we analyse the increase in hepatitis A cases notiﬁed in
Germany between September 2015 and March 2016. Speciﬁcally, we
investigate HAV transmission within the group of asylum seekers after
arrival to Germany and the potential of transmission into the
residential population. To this end, we assess autochthonous HAV
transmission among asylum seekers and analyse transmission chains
by molecular surveillance. With our report, we aim to guide public
health measures mainly in regard to arriving asylum seekers but also
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for the general population in order to prevent further secondary
transmission events of HAV.
MATERIALS AND METHODS
Main investigation
In Germany, all hepatitis A cases are notiﬁable to local health
departments irrespective of nationality or status of residence of the
case. Local health departments are responsible for case investigations
and prevention measures. Individual case data are compiled in a case
report, anonymized and electronically transmitted to the state health
department and further to the Robert Koch Institute (RKI).10–12 We
analysed the German national surveillance data for the period from
September 2015 to March 2016 and ascertained imported and
autochthonous hepatitis A cases in asylum seekers. Furthermore, we
investigated frequency and sizes of hepatitis A outbreaks related to
arriving asylum seekers. In addition, to examine possible chains of
HAV transmission between asylum seekers and to conﬁrm clusters in
mass accommodations, we performed molecular typing in cooperation
with the national consultant laboratory for HAV (University Medical
Centre Regensburg, Germany).
Deﬁnition of the term asylum seeker
The term asylum seeker was used in order to describe individuals that
—for any reason—applied for asylum or had the intention to apply
for asylum in Germany. In the investigated period, between September
2015 and March 2016, these individuals were mainly, but not
exclusively refugees ﬂeeing from conﬂict regions in the Middle East
or East Africa.
Age deﬁnitions
In our study, children refers to individuals aged 0–12 years, teenagers
12–19 years, adolescents 13–17 years and adults 418 years,
respectively.
Collection of case data and material for molecular surveillance
The German Protection against Infection Act (IfSG) authorizes local
health departments to investigate the context of cases and to arrange
appropriate prevention measures. To this end, there are no predeﬁned
standard operation procedures. However, cases are usually contacted
and interviewed by a local health ofﬁcer. After anonymization of
patient data, gathered information is categorized in predeﬁned
reporting categories and recorded in the national surveillance
data base.
For this report, we speciﬁcally analysed demographic variables
introduced into the surveillance system in September 2015, allowing
a differentiation of residents and asylum seekers. This recent addition
to the surveillance system was made in reaction to the strong inﬂux of
asylum seekers in the second half of 2015 to provide data on the
impact of this population increase on the surveillance data.
For investigation of molecular clusters, sampling is not mandatory
in Germany. However, local health departments are encouraged to
cooperate with the national consultant laboratory for secondhand use
of collected clinical material or, occasionally, sample additional
material from cases (for example, stool) for molecular analyses.
Case deﬁnition
A case of hepatitis A was deﬁned as an individual with one of the
following clinical symptoms indicative of acute hepatitis: fever,
abdominal pain, icterus, elevated transaminases and additionally a
laboratory conﬁrmation of a present HAV infection (typically based
on IgM or PCR) or alternatively with an epidemiological link to a
laboratory-conﬁrmed case. Asymptomatic cases, not meeting the
predeﬁned case deﬁnition, were not considered in this study.
Statistical data on asylum seekers
Baseline statistics of arriving asylum seekers, for example, counts,
country of origin and age distribution were adopted from published
documents of the Federal Ofﬁce for Migration and Refugees or
requested from there.13 Asylum seekers primarily originated from
regions where HAV is endemic, Syria (50.9%), Iraq (11.1%),
Afghanistan (9.5%), Albania (5.2%), Eritrea (1.8%), Pakistan (1.8%)
and Serbia (1.3%). According to the WHO criteria, the level of HAV
endemicity by country of origin was mainly intermediate, except for
asylum seekers from East Africa (high) and from the Western Balkan
countries (intermediate to low).
Classiﬁcation of imported and autochthonous cases
The incubation period of hepatitis A is 30 days on average and ranges
from 15 to 50 days.14 In order to quantify the proportion of imported
vs. autochthonous hepatitis A cases, we calculated the number of days
between arrival in Germany and the reported onset of symptoms and
analysed the respective distribution. We classiﬁed cases into impor-
ted (onset o15 days post arrival in Germany), probably imported
(15–29 days), probably autochthonous (30–50 days) and autochtho-
nous (450 days) cases.
Deﬁnition of hepatitis A outbreaks
A hepatitis A outbreak is the occurrence of a cluster with two or more
cases of hepatitis A with an epidemiological link (for example, a
conﬁrmed or assumed identical source of infection).
Statistical analysis
All hepatitis A cases notiﬁed between September 2015 and March 2016
were extracted from the national surveillance database SurvNet and
transferred to Microsoft Excel for data management. We employed
GraphPad Prism for basic statistical procedures and graphical pre-
sentation. When comparing multiple groups and Gaussian distribution
was not assumed, data were analysed by Kruskal–Wallis test; a value of
Po0.05 was considered to be statistically signiﬁcant.
Molecular typing of the VP1/P2A region of HAV samples
Molecular analyses were performed at the national consultant
laboratory for HAV. In order to enable cluster analysis using
molecular methods, local health departments were asked to provide
blood samples of sporadic and outbreak cases of hepatitis A for
molecular typing. Nucleic acid isolation was performed using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) with 100 μL elution
volume (RNase-free water). A 10 μL aliquot of the eluate was used for
reverse transcription in a total reaction volume of 20 μL using
Moloney murine leukaemia virus (M-MuLV) reverse transcriptase
(Applied Biosystems, Foster City, CA, USA) and random hexamers
according to the manufacturer’s instructions (42 °C, 30 min). Two
replicates were analysed in 30 μL PCRs each containing 10 μL of the
RT product (corresponding to 5 μL eluate), ROX buffer, 5.0 mmol/L
MgCl2, 1.25 U AmpliTaq Gold DNA polymerase (all Applied
Biosystems), dNTPs, speciﬁc primers (300 nmol/L each) and TaqMan
hydrolysis probe (200 nmol/L). Primers and probe for the HAV
reverse transcription quantitative real-time PCR (RT-qPCR) assay
were in the viral polymerase gene region (SH-Poly-A, SH-Poly-1 and
SH-Poly-Q15). Thermal cycling was performed on a StepOnePlus
instrument (Applied Biosystems) and comprised a 10-min initial
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enzyme activation step at 95 °C, and 45 cycles of 95 °C for 15 s and
60 °C for 1 min.
RT-qPCR-positive samples were further characterized by amplicon
sequencing. The ampliﬁcation was performed according to the uniﬁed
HAV Net protocol (http://www.rivm.nl/en/Topics/H/HAVNET) by
using speciﬁc primers for the HAV VP1/P2A genomic region (HAV
6.1, 5′-TAT GCY ITI TCW GGI GCI YTR GAY GG-3′; HAV 10,
5′-TCY TTC ATY TCW GTC CAY TTY TCA TCA TT-3′, 614 nt).
A 2.5 μL aliquot from the ﬁrst round of PCR was then used as a
template in the second round of PCR with primers HAV 8.2,
5′-GGA TTG GTT TCC ATT CAR ATT GCN AAY TA-3′ and
HAV 11, 5′-CTG CCA GTC AGA ACT CCR GCW TCC ATY TC-3′
(518 nt). The PCR products were puriﬁed by using QIAquick columns
(Qiagen) and sequenced in both directions with the second-round
ampliﬁcation primers.
Nucleotide sequences of amplicons were determined by using the
BigDye Terminator Cycle Sequencing Kit (Applied Biosystems) and
separated on a model 3730xl genetic analyser (Applied Biosystems).
Sequences were analysed by using CodonCode Aligner 5.1.5 software
(CodonCode Corporation, Centerville, MA, USA).
GenBank and local sequence databases were searched for sequences
with high similarity using the BLAST and FASTA algorithms. A rooted
maximum likelihood phylogenetic consensus tree for VP1/P2A
nucleotide sequences was inferred using RAxML 8.2.7 software
(http://sco.h-its.org/exelixis/web/software/raxml).
RESULTS
Notiﬁed hepatitis A cases from September 2015 to March 2016 in
Germany
From September 2015 to March 2016 hepatitis A notiﬁcations in
Germany rose by 45% (217 cases) to 699 cases compared to 482 cases
in the same period in 2014/2015 (median of the previous ﬁve
notiﬁcation periods September to March: 493 cases). Of all 699
hepatitis A cases notiﬁed between September 2015 and March 2016,
male cases were overrepresented with a proportion of 59%. Regarding
age, children aged ﬁve to nine years were predominantly affected and
accounted for 22% of the 699 cases notiﬁed in this period.
Hepatitis A incidence in asylum seekers
In total, 278 cases of hepatitis A in asylum seekers were reported
between September 2015 and March 2016, and accounted for 40% of
the 699 notiﬁed hepatitis A cases in Germany (Figure 1). In this
period, hepatitis A was among the ﬁve most frequently notiﬁable
infectious diseases in Germany for asylum seekers. The remaining 421
cases out of the 699 hepatitis A cases notiﬁed from September 2015 to
March 2016 in Germany were cases within the residential population,
but presumably included an unknown number of cases being
unclassiﬁed asylum seekers (due to incomplete notiﬁcations of asylum
status). From September 2015 to March 2016, a total of 852 066
arriving asylum seekers were ofﬁcially recorded by the Federal Ofﬁce
for Migration and Refugees in Germany. Using this ofﬁcial ﬁgure as
the denominator of the arriving population, we calculated the
reporting incidence of hepatitis A in asylum seekers as compared to
the residential population. The German residential population totalled
81.8 million residents in 2015. With 278 hepatitis A cases occurring
per 852 066 asylum seekers and 421 cases per 81.8 million German
residents, the reporting incidence of hepatitis A amounted to 32 per
100 000 and 0.5 per 100 000, respectively (reporting incidence ratio
(95% conﬁdence interval (95% CI)): 63 (54–73; Po0.0001).
Imported versus autochthonous hepatitis A cases in asylum seekers
Both arrival and disease onset dates were available for a total of 153
(55%) hepatitis A cases in asylum seekers notiﬁed from September
2015 to March 2016 in Germany. The respective distribution of the
reported times-to-disease onset after arrival is depicted in Figure 2.
Time-to-disease onset after arrival ranged from 0 to 192 days. Most
hepatitis A cases in asylum seekers occurred within a few days after
arrival to Germany. Correspondingly, the majority (53%) of arriving
asylum seekers was infected before arrival in Germany, as denoted by
time-to-disease onset after arrival of o30 days and the related 53rd
percentile of the analysed distribution. The remaining 47% were
autochthonous hepatitis A cases with HAV infections acquired after
arrival in Germany. The 53% imported hepatitis A cases split into 36%
of clearly imported cases (disease onset o15 days after arrival) and
17% of probably imported cases (15–30 days after arrival). The 47%
autochthonous hepatitis A cases split into 24% of clearly
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Figure 1 Epidemic curve of notiﬁed hepatitis A cases by week and year of notiﬁcation, Germany, January 2015 through March 2016 (n=1126).
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autochthonous cases (disease onset450 days after arrival) and 23% of
probably autochthonous cases (30–50 days after arrival).
Age distribution of hepatitis A cases from September 2015 to March
2016 in Germany
Median age of all 699 hepatitis A cases notiﬁed between September
2015 and March 2016 in Germany dropped markedly to 18 years
(interquartile range (IQR): 8–45 years) as compared to the median age
of all 482 hepatitis A cases notiﬁed 1 year before (29 years, IQR: 11–58
years). In the ﬁve preceding periods from September to March in
2010/2011 to 2014/2015 median age was 30 years (IQR: 11–55 years)
and the age distribution was largely similar (Figure 3).
The median age of the 278 asylum seekers out of the 699 hepatitis A
cases notiﬁed between September 2015 and March 2016 was nine
years (IQR: 5–17 years) and the median age of the remaining 421
hepatitis A cases in German residents was 32 years (IQR: 13–59 years).
Children or teenager aged 0–19 years accounted to 53% (373 cases)
of all 699 hepatitis A cases notiﬁed from September 2015 to March
2016. The proportion of children aged 5–9 years was 22% (155 cases)
of all 699 cases notiﬁed in this period.
Age distributions of arriving asylum seekers and of hepatitis A cases
in this group
Between September 2015 and March 2016, particularly young adults
ﬂed to Germany and are thus overrepresented among arriving asylum
seekers. In this speciﬁc background population, asylum-seeking
children and teenagers aged 0–19 years accounted for 37%, while
children aged 5–9 years for 8% of all arriving asylum seekers
(Figure 4A). Among all 278 hepatitis A cases in asylum seekers
notiﬁed from September 2015 to March 2016 in Germany, children
and teenagers aged 0–19 years accounted for 83% (231 cases), while
children aged 5–9 years for 35% (97 cases; Figure 4B).
Notiﬁed hepatitis A outbreaks
In total, 192 cases of the 278 cases in asylum seekers notiﬁed between
September 2015 and March 2016 were linked to outbreaks of hepatitis
A. Overall, 78 outbreaks were notiﬁed in this period, 50 (64%) of these
outbreaks were related to HAV transmissions in asylum seekers, and
occurred mainly in mass accommodations. Cluster sizes of hepatitis A
outbreaks that were related to asylum seekers included up to eight
cases with a median of two cases (IQR: 2–3 cases).
In the reference period, from September 2014 to March 2015,
hepatitis A outbreaks in Germany totalled 44. Although the number of
hepatitis A outbreaks almost doubled (increase of 77%), the cluster
sizes did not signiﬁcantly differ (P= 0.33, Kruskal–Wallis test) from
the respective ﬁve preceding periods (September to March in
2010/2011 to 2014/2015).
With the exception of a singular transmission from an asympto-
matic child to a nursery nurse working in a mass accommodation, we
are unaware of transmissions of HAV between asylum seekers and the
German residential population.
Molecular analysis of HAV strains in hepatitis A clusters
Samples of stool, blood or serum from 21 hepatitis A cases in asylum
seekers were sent for molecular sequence typing to the national
consultant laboratory for HAV. Among the analysed samples 19 (90%)
of the VP1/2A sequences were closely related and subgenotype IB,
while two (10%) were subgenotype IIIA. Overall, we observed four
clusters of nearly identical IB and IIIA sequences among the analysed
HAV strains. The molecular signature of the sequenced samples
related to HAV strains previously isolated from samples in the Middle
East, Turkey, Pakistan and East Africa.16 The phylogenetic relations of
all analysed HAV samples of arriving asylum seekers together with the
previously analysed sequences of HAV reference strains are depicted in
Figure 5.
DISCUSSION
In 2015, the so-called refugee crisis put strong pressure on the
European public health systems.18 In Germany, the number of asylum
seekers peaked in the second half of 2015, with more than 800 000
people arriving.19 Due to the different geographical origin and the very
often extremely challenging travel conditions to and in Europe,
R
el
. f
re
qu
en
cy
 (%
)
imported autochthonous
0 15 30 50 days after arrival
Average incubation time of hepatitis A: 30 days (range 15-50 days)
Disease onset after arrival in Germany (days)
imported autochthonous
probably probably
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 10
0
10
5
11
0
11
5
12
0
12
5
13
0
13
5
14
0
14
5
15
0
15
5
16
0
16
5
17
0
17
5
18
0
18
5
0
5
10
15
20
19
0
Figure 2 Histogram of reported disease onset of hepatitis A relative to arrival in Germany (n=153 cases of asylum seekers).
Hepatitis A in asylum seekers arriving to Germany
K Michaelis et al
4
Emerging Microbes & Infections
migrants are vulnerable to different infectious diseases than the ones
affecting most of the EU resident population.9,18
In this paper, we report an increase of hepatitis A notiﬁcations in
Germany from September 2015 to March 2016 in temporal connec-
tion to the marked inﬂux of asylum seekers. We hypothesized that a
large proportion of the observed increase in hepatitis A notiﬁcations in
Germany can be—at least partially—attributed to the 278 cases in
asylum seekers. We demonstrate that the increase in hepatitis A
notiﬁcations in 2015/2016 compared to 2014/2015 is of the same
magnitude as the number of hepatitis A cases notiﬁed for arriving
asylum seekers in this period (217 vs 278 cases) and, thus, is able to
explain the increase of hepatitis A notiﬁcations in Germany.
However, the differentiation of the notiﬁed hepatitis A cases into
residents and asylum seekers in Germany was only feasible after the
introduction of additional variables into the national surveillance
system in September 2015 implemented in reaction to the strong
inﬂux of asylum seekers in the second half of 2015. Therefore, no data
on the residential status (asylum seeker or German resident) of
hepatitis A cases before September 2015 is available as baseline
information. We assume that the differentiation into residents and
asylum seekers was still incomplete and would be primarily biased by
unclassiﬁed asylum seekers in the notiﬁcation system and, therefore
resulted in an underestimation of hepatitis A cases in asylum seekers.
The increase of hepatitis A notiﬁcations in Germany reﬂects that
arriving asylum seekers are largely exposed to HAV due to the fact that
they predominantly originated from HAV endemic areas, for example,
Middle East or Africa and, moreover experienced difﬁcult hygienic
and living conditions while migrating to Germany. Importantly, the
level of HAV endemicitiy in the country of origin affects the level of
naturally acquired immunity to HAV of children and adults in
particular. Thus, WHO differentiates endemic areas into low, inter-
mediate and high.20 In Germany, the incoming populations of asylum
seekers originated mainly from intermediate (Middle East), low to
intermediate (Albania and Serbia) but also from regions with high
HAV endemicity (East Africa). In our study however, we could not
differentiate hepatitis A cases in asylum seekers depending on their
region of origin. Nevertheless, the reporting incidence ratio of 63 for
hepatitis A when comparing asylum seekers as against the German
general population underscores the comparatively high reporting
incidence among this group. Of note, our calculation of the reporting
incidence of hepatitis A in asylum seekers and the respective reporting
incidence ratio referred to ofﬁcially registered arrivals of asylum
seekers who intended to apply for asylum in Germany (denominator)
captured by the German EASY system.2,19 We are aware that the exact
number of arriving asylum seekers is hard to establish and the ofﬁcial
ﬁgures might be subject to bias. However, this denominator—
although it might be biased by misregistered or double-counted but
also unregistered asylum seekers—should give at least a rough estimate
of the arriving population and of the resulting reporting incidence of
hepatitis A among asylum seekers.
Because of the aforementioned high exposure to HAV before
coming to Germany, a large proportion of HAV infections in asylum
seekers could be regarded as imported. Indeed, most hepatitis A cases
in arriving asylum seekers occurred within a few days after arrival.
However, taking into account arrival and disease onset dates and
hepatitis A incubation time, as many as 24%–47% of HAV infections
in asylum seekers are HAV infections apparently acquired in mass
accommodations after arrival in Germany. The range of 24%–47%
reﬂects the range of the incubation period of hepatitis A cases: 24% are
very likely and further 23% were most likely acquired in Germany,
pointing to a relatively high rate of ongoing transmissions within the
group of asylum seekers after arrival to Germany.
By sequence typing of HAV samples from hepatitis A cases in
arriving asylum seekers and phylogenetic analysis of the sequences, we
could demonstrate that the samples are closely related to strains
previously isolated from samples in the Middle East, Turkey, Pakistan
and East Africa. These regions are known for endemic HAV
circulation and are either starting points or located on the transit
routes used by asylum seekers that ﬂed to Europe in 2015/2016.
Interestingly, 90% of the VP1/2A sequences we investigated are closely
related and belong to subgenotype IB, while 10% were subgenotype
IIIA. This is in contrast to the large food-associated hepatitis A
outbreaks during the past years, where subgenotype IA was
prevalent.21,22 In our study, we observed several clusters of identical
HAV sequences that suggested transmission among asylum seekers.
Although we cannot completely exclude common sources of infection
before asylum seekers arrived to Germany, these clusters might
represent transmissions after arrival within the housing facilities for
asylum seekers.
In the investigated period between September 2015 and March
2016, we noted a sharp decline in the median age of notiﬁed hepatitis
A cases in Germany compared to the respective periods of previous
years. In our report, we demonstrate that the decline is largely
attributable to hepatitis A cases in asylum-seeking children. The age
distribution of hepatitis A cases in the residential population remained
unchanged as compared to previous years. Of note, our case deﬁnition
does not include hepatitis A infections without symptoms, which are
frequently observed in children. Assuming comparable infection risks
for asylum seeking children aged one to four years compared to
asylum seeking children aged ﬁve to nine years, the much lower
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reporting incidence observed in the former-mentioned group may
indicate that circulation of HAV especially in this group is largely
underestimated (Figure 4).
The observed high number of hepatitis A cases in asylum-seeking
children and adolescents was not explainable by the unique age
distribution of the arriving population. Comparing the age distribu-
tions of arriving asylum seekers and notiﬁed cases of hepatitis A in this
group, reveals a strong relative overrepresentation of hepatitis A cases
in asylum-seeking children and adolescents. This is in line with the
observation that adult asylum seekers from countries where HAV is
intermediately to highly endemic, such as Syria, might have acquired
already a natural immunity to HAV.20 In addition, it mirrors the
different vaccination recommendations of the WHO for hepatitis A,
where regions are classiﬁed into low, intermediate and high HAV
circulation. Overall, our data thus reveal the high level of exposure of
asylum seekers to HAV, the occurrence of HAV transmission in mass
accommodations, and, thus, suggest ongoing HAV circulation within
this group after arrival in Germany. Speciﬁcally, we demonstrate that
asylum-seeking children and adolescents are predominantly affected,
both for imported and also autochthonous HAV infections.
As HAV infection and also vaccination confers immunity to HAV
for decades, we suggest serological testing should be offered free-of-
charge to clarify if immunity to HAV is already present. Essentially,
hepatitis A virus immunization of asylum-seeking children and
adolescents needs to be considered, although practical (vaccination
schedule) and economical aspects may hinder the introduction of a
general vaccination program. This would particularly prevent hidden
infection chains and virus circulation that might possibly occur in
connection to the admission of asylum-seeking children and adoles-
cents into schools or day-care facilities, and impede HAV transmis-
sions of asymptomatic cases into the residential population. The
available hepatitis A virus vaccines are safe and highly effective and
employed for routine childhood vaccination programs in some parts
of the world.23–27 On that note, a single-dose hepatitis A vaccine was
previously reported to be sufﬁcient to confer long-lasting immunity to
HAV.28 Furthermore, information campaigns could reinforce the
awareness of infection risks and instruct on the prevention of HAV
transmission. Vaccination and instructions on the prevention of HAV
transmission should primarily target asylum seekers but also nursery
nurses, teachers, assistants and staff in mass accommodations. In this
context, the Standing Committee on Vaccination in Germany
recommends vaccination against hepatitis A viruses for occupational
indication for all volunteers or employees and others that are taking
care for asylum seekers.
Moreover, we hypothesize that HAV transmission can be reduced if
the housing conditions improve during the process of integrating
asylum seekers into the residential population. Because crowding, poor
sanitation and inadequate hygiene are well-established factors that are
causative for faecal–oral transmission of HAV and particularly housing
conditions in mass accommodations seem to be suboptimal to
interrupt HAV transmission chains.
We report a substantial number of hepatitis A outbreak notiﬁca-
tions from September 2015 to March 2016 in relation to asylum
seekers admitted in mass accommodations. Apparently, regardless of
strong efforts to accommodate asylum seekers under suitable living
conditions, hepatitis A virus transmission was not completely avoid-
able. Nevertheless, cluster sizes of up to eight cases with a median of
two cases do not signiﬁcantly differ compared to previous years and
point to effective control measures within the German public health
system. Once hepatitis A cases were ascertained, extended hygiene
measures, case isolation and post-exposure prophylaxis have been
exerted to prevent secondary hepatitis A virus transmission.29,30
Hence, local health departments have to remain vigilant to interrupt
HAV transmission chains as early as possible to prevent further
spread. In the investigated period, between September 2015 and
March 2016, only a singular report of HAV transmission into the
general population was reported to the Robert Koch Institute. Thus,
spread of HAV seems to have been restricted to transmission within
the group of asylum seekers and transmission to the German
residential population was almost completely avoided highlighting
the importance of rigorous hepatitis A surveillance and case manage-
ment activities by public health authorities.
On that note, after the period of September 2015 to March 2016,
hepatitis A notiﬁcations in Germany declined to levels comparable to
previous years. We assume that in addition to successful public health
measures also declining numbers of arriving asylum seekers in the ﬁrst
half of 2016 contributed markedly to reduced hepatitis A notiﬁcations
in Germany. Thus, the observed increase of hepatitis A notiﬁcations in
the last months seems to be entirely attributable to the reception of
large numbers of refugees in the European Union.
In our study, the outlined increase of 45% in hepatitis A
notiﬁcations between September 2015 and March 2016 in Germany
refers to the preceding reference period of September 2014 to March
2015. To consider possible ﬂuctuations of hepatitis A case counts in
the surveillance system, we also included the median value of the
respective ﬁve preceding time intervals that was nearly of the same
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magnitude and resulted in an increase of 42%. Overall, the increase of
hepatitis A notiﬁcations in Germany was observed after an almost
steadily decreasing trend in the last decade.
In summary, our report underlines that HAV transmission among
asylum seekers is a relevant issue, particularly in asylum-seeking
children and adolescents, but can be effectively mitigated by rigorous
hygiene measures, case isolation and post-exposure prophylaxis. The
high reporting incidence of hepatitis A in asylum seekers, that is
largely limited to children, reﬂects the endemicity of HAV in the
countries of origin and, additionally, the high exposure risk related to
poor hygienic standards when asylum seekers ﬂee to Europe. A large
proportion of adult asylum seekers that originated from regions with
intermediate or high HAV endemicity however, were largely exposed
to HAV prior escaping their country of origin and acquired a natural
immunity to HAV.31 Secondly, outbreaks of hepatitis A in mass
accommodations were effectively controlled and of limited size, also
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the risk of HAV transmission into the residential population remained
low. We are conﬁdent that the high vulnerability for migration-related
sources of infections like HAV decreases as integration progresses. To
this end, living conditions of asylum seekers ought to improve and
converge towards those of the general population.
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